Treatment of mice with a TLR2/6 agonist (Pam2CSK4, “Pam2”) alone or a TLR9 agonist (ODN2395, “ODN”) alone resulted in no protection against lethal influenza pneumonia. This evidence concerns the gene TLR9 and pneumonia.